Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder — NEJM

Retweeted NEJM (@NEJM): Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder. Pub online 12/25. http://t.co/7avFqVEMZG

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/7avFqVEMZG